{"id":5343,"date":"2011-07-14T20:25:39","date_gmt":"2011-07-14T20:25:39","guid":{"rendered":"http:\/\/crashtext.org\/misc\/5343.htm\/"},"modified":"2011-10-02T19:51:51","modified_gmt":"2011-10-02T19:51:51","slug":"fever-sepsis","status":"publish","type":"post","link":"https:\/\/crashingpatient.com\/pediatrics\/fever-sepsis.htm\/","title":{"rendered":"Pediatric Fever and Sepsis"},"content":{"rendered":"
<\/p>\n
<\/p>\n
<\/p>\n
ACEP=Clinical Policy of ACEP (Annals of EM 42:4, Oct 2003)<\/p>\n
<\/a><\/p>\n 0-1 Month:\u00a0 Amp (50-100 mg\/kg) + Gent (2.5 mg\/kg) or Amp + Cefotaxime (50 mg\/kg)<\/p>\n 1-3 Month:\u00a0 Amp + Cefotaxime or Amp +Ceftriaxone (50-100 mg\/kg) or Amp + Chloramphenicol<\/p>\n 3-24 Month:\u00a0 Ceftriaxone<\/p>\n >24 Month:\u00a0 Ceftriaxone<\/p>\n Immunocomprimised:\u00a0 Vanco (15 mg\/kg) + Ceftazidime (50 mg\/kg) + Ticarcillin (75 mg\/kg)<\/p>\n <\/p>\n WBC at any level has crappy sensitivity and specificity (Ann Emerg Med 2003; 42:2, 216-225)<\/p>\n and (Ann Emerg Med 42:2, 206, 2003)<\/p>\n <\/p>\n Infants between 1-28 days with a fever should be presumed to have serious infection (ACEP)<\/p>\n <\/p>\n The principal finding of this study is that UTIs were not uncommon in febrile, RSV-positive infants 0-90 days old in whom urine cultures were obtained (prevalence rate = 7.2%, 95% CI = 2.4-16.1) (Pediatric Emergency Care 2003; 19(5):314-319)<\/p>\n <\/p>\n <\/a><\/p>\n bacteremia in children aged 2\u009624 months who presented to the pediatric ED in whom they found a prevalence of bacteremia of 1.9%. Of these pathogens, S. pneumoniae<\/em> accounted for 83% and no H. flu<\/em> was identified (JEM Aug 2003)<\/p>\n <\/p>\n Latest data post HIB\/strep pneumo vaccinations estimate 1.5-2%.\u00a0 5-20% of those will progress to more serious infection.\u00a0 However when previously well children are looked at, 0.3% develop serious sequelae and only 0.03% will develop sepsis or meningitis. (ACEP)<\/p>\n <\/p>\n It seems reasonable, therefore, to treat all patients who are in the high risk category with an initial dose of parenteral antibiotics, and if S. pneumoniae<\/em> is found on blood culture, to consider outpatient treatment with appropriate oral antibiotics for 7\u009610 days in children over 2\u00963 months of age. Other pathogens grown on blood culture also merit consideration\u0096\u0096there has been shown to be a rate of false-positive blood cultures (i.e., non-pathogenic) of around 0.9% [16<\/a>]. For any patient aged 3\u009636 months whose blood culture reveals a pathogen, prompt re-evaluation is necessary. At least one study has shown that a single dose of parenteral antibiotics at the initial visit can eradicate bacteremia in patients with bacteremia caused by S. pneumoniae, H influenzae<\/em> type b, Salmonella<\/em> and N. meningitides<\/em> [17<\/a>]. If the patient is non-toxic, has no focal bacterial infection, and is well-appearing at a 24-h follow-up visit and received parenteral antibiotics at the first visit, a reasonable course of action would be to commence oral antibiotics, selected on the basis of what pathogen is grown and sensitivities (although duration of therapy is not well established). However, if patients with a positive blood culture have a persistent fever, are ill-appearing, have developed a bacterial focus of infection, or are less than 3 months of age, inpatient parenteral antibiotic therapy should be instituted [8<\/a>].<\/p>\n <\/p>\n<\/span>3-36 Months:\u00a0 Occult Bacteremia<\/span><\/h2>\n